1
Total investments
1
Early stage
0
Mid stage
0
Late stage
6y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Sep 2020
ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company re-envisioning the treatment of "cold" tumors, particularly of immune-excluded tumors. Immune-excluded tumors, which account for more than half of all cancers, are characterized by having mechanisms of resistance that suppress the immune response; this subgroup is resistant to current immunotherapies. ImmunoGenesis is creating therapies based on the pathology of these immune-excluded tumors that are rationally designed to overcome immune exclusion and thereby drive an effective immune response.
We look at cold, immune-excluded tumors through a new lens, re-envisioning treatment with a deliberate drug development strategy based in cold tumor pathology.
Experience · 3 entries
All (3)
Investments (1)
Founder (1)
2020
Partner
Sep 2020
We are a team of dreamers and doers, entrepreneurs and hard workers, go-out-of-our-way-to-help-ers and (not so) silent supporters. As an early-stage venture capital firm, we get to proactively back the disruptors and changemakers of the world. We could tell you about the long-term value we provide our portfolio companies through our platform, network, and relationships, but we’re not the stars of the show here. We’d prefer to shine a spotlight on the leaders of our portfolio companies who are putting in the real work.
Investor
Sep 2020
ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company re-envisioning the treatment of "cold" tumors, particularly of immune-excluded tumors. Immune-excluded tumors, which account for more than half of all cancers, are characterized by having mechanisms of resistance that suppress the immune response; this subgroup is resistant to current immunotherapies. ImmunoGenesis is creating therapies based on the pathology of these immune-excluded tumors that are rationally designed to overcome immune exclusion and thereby drive an effective immune response.
We look at cold, immune-excluded tumors through a new lens, re-envisioning treatment with a deliberate drug development strategy based in cold tumor pathology.
2010
Co-Founder
Sep 2010
Juno Search Partners is a women-founded and women-led talent solutions firm working every day to connect the right people with the right kind of place.
Our collaborative team of experienced sourcers and recruiters specialize in assisting growing companies to build out their workforce through custom-built recruitment solutions. We have extensive experience in the placement of accounting, administrative, finance, human resources, legal, marketing, talent acquisition, and tech candidates nationwide.
By offering a multitude of service solutions — contingent search, retained search, contractor placement, executive search, custom talent solutions, and payroll services - we can help you get the talent you need, delivered in a way that makes the most sense for your organization.
Were really good at what we do. (Like really good.) Here’s proof:
• Philly100 – 2013, 2014, 2015, 2019, 2020, 2022
• Inc. 5000 – 2015, 2016, 2017, 2019, 2020, 2022
• Soaring 76 – 2019, 2020
• PBJ Best Places to Work – 2019, 2022
• HR Person of the Year nominees – 2016, 2018, 2022
As the Ultimate Connectors we value our ability to bring many different perspectives to the table in order to enhance teams. We are committed to connecting people of every race, ethnicity, gender identity, sexual orientation, age, socio-economic status, physical ability or attribute, religion, national origin, or political belief. We recognize that this commitment requires ongoing work and sustained attention, as well as adaptation to new insights and best practices.
